CRSP CRISPR Therapeutics AG | CH0334081137
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 4.583.451.648 | 4.585.058.491,01 | 5.028.699.110,35 | 6.083.895.549,96 |
| Enterprise Value | 2.834.583.808 | 4.949.392.491,01 | 4.887.886.110,35 | 6.008.422.549,96 |
| Trailing P/E | - | - | - | - |
| Forward P/E | -11,97 | - | - | - |
| Price to Sales | 1.117,1 | 4.585,06 | - | - |
| Price to Book | 2,47 | 2,53 | 2,62 | 3,18 |
| EV/Revenue | 690,86 | 4.949,39 | - | - |
| EV/EBITDA | -5,34 | - | - | - |